1DROP Diagnostics

📍 Neuchâtel, Switzerland🗓 Founded 2012👥 9 employees💰 Last funded Oct 2018
Biotechnology Research🌐 1dropdx.com
Website LinkedIn
1DROP’s goal is to improve patient lives by enabling personalized healthcare through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. 1DROP facilitates the early detection, prevention and management of disease and empowers people to live better lives. 1DROP highly values collaboration, prioritizing the needs of customers and rapidly delivering solutions. 1DROP’s innovative diagnostic solutions for multiplexed assays of proteins, nucleic acids and peptides serve as tools for the development of new therapies and drugs, disease research, and clinical diagnostic tests. The company is based in Neuchatel, Switzerland and Boston, United States and is supported by some of the most highly regarded experts in the field of biosensors.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2012
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in 1DROP Diagnostics?
1DROP Diagnostics has 1 investors on record on gritt.io and 1 late-stage investors.
When did 1DROP Diagnostics last raise funding?
The most recent investment in 1DROP Diagnostics recorded on gritt.io was in October 2018.
When was 1DROP Diagnostics founded?
1DROP Diagnostics was founded in 2012.
What industry is 1DROP Diagnostics in?
1DROP Diagnostics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is 1DROP Diagnostics based?
1DROP Diagnostics is headquartered in Neuchâtel, Switzerland.